ArticleHeliyon2024
XCR1: A promising prognostic marker that pinpoints targeted and immune-based therapy in hepatocellular carcinoma.
Wei Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleHeliyon2024
Wei Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.